This compound is primarily utilized in the development of pharmaceuticals, particularly as a key intermediate in the synthesis of boron-containing drugs. Its unique structure, featuring a fluorine atom and a boronic acid group, makes it valuable in creating inhibitors for enzymes like proteases and kinases, which are often targeted in cancer and inflammatory diseases. Additionally, it is employed in the design of novel antibiotics, leveraging its ability to interact with bacterial enzymes and disrupt their function. Its boron moiety also plays a role in neutron capture therapy, a promising approach for treating certain types of cancer.